Gilead Sciences (GILD) PT Lowered to $89 at Maxim Group
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $125.78 +0.73%
Rating Summary:
36 Buy, 7 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 4 | Down: 13 | New: 23
Rating Summary:
36 Buy, 7 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 4 | Down: 13 | New: 23
Join SI Premium – FREE
Maxim Group lowered its price target on Gilead Sciences (NASDAQ: GILD) to $89.00 (from $94.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU approves Gilead's Trodelvy for first-line metastatic TNBC
- Take-Two Interactive (TTWO) PT Raised to $368 at BofA Securities
- Allegiant Travel Company (ALGT) PT Raised to $103 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Maxim GroupSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
